Corticosteroids for systemic use
Supply of medicinal products containing the active substance Prednisone (ATC H02AB07) for oral administration for the treatment of patients in approved indications. Prednisone in 5 MG/tablet strength is mandatory. Additional strengths (2.5 MG/tablet, 10 MG/tablet, 20 MG/tablet) are optional; the breadth of the portfolio will be evaluated.
CONTRACTING AUTHORITY
Name
Institut klinické a experimentální medicíny
City
Praha
Country
CZ
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33642200, Corticosteroids for systemic use.
ADDITIONAL DETAILS
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
42 days remaining(LOT-0001)
Published